CanSino rallies 76% on the promise of inhaled COVID-19 vaccine

Nov. 02, 2022 12:53 PM ETCanSino Biologics Inc. (CASBF)SFOSF, SHJBFBy: Dulan Lokuwithana, SA News Editor

Abs COVID-19 pandemic

koto_feja/E+ via Getty Images

  • Vaccine maker CanSino Biologics Inc. (OTCPK:CASBF) added ~76% on Wednesday after the company announced that more Chinese would follow Shanghai in deploying its inhaled COVID-19 vaccine.
  • The Tianjin-based company said in its official social media account that

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.